Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Sees Rx Synergies In Guidant Deal; Big Buy Does Not Rule Out More Deals

Executive Summary

J&J's acquisition of Guidant will open up new areas of opportunity for collaboration between the pharmaceutical, device and diagnostic operations of the company, CEO William Weldon declared during a Dec. 16 analysts conference call

You may also be interested in...



Pfizer To Use Cash From Sale Of OTC Unit To J&J For Biotech, Specialty Deals

Pfizer will use the cash gained through the sale of its consumer unit to Johnson & Johnson to make targeted specialty pharma and biotech acquisitions, the firm said following announcement of the deal June 26

Pfizer To Use Cash From Sale Of OTC Unit To J&J For Biotech, Specialty Deals

Pfizer will use the cash gained through the sale of its consumer unit to Johnson & Johnson to make targeted specialty pharma and biotech acquisitions, the firm said following announcement of the deal June 26

J&J Ready To Re-Balance? Guidant Deal Would Decrease Dependence On Rx

Johnson & Johnson's proposed acquisition of Guidant will help the company restore the balance in its health care portfolio

UsernamePublicRestriction

Register

SC143384

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel